| This week's sponsor is INC Research. | | | |
Top Stories Thursday, October 6, 2016 Arrowhead Pharmaceuticals and Spring Bank Pharmaceuticals have partnered to test a couple of hepatitis B candidates in combination. Thursday, October 6, 2016 Teva and Korea’s Celltrion have come together to form a biosims commercial pact as the Israeli generics giant aims for deeper ties in the growing biologic copies space--and a new partner after Lonza backed away in 2013. Wednesday, October 5, 2016 The candidate just won a breakthrough designation from the FDA and priority medicine status from the EMA in July, with an FDA submission expected next year. Thursday, October 6, 2016 Medicxi is putting up €10 million ($11.1 million) to support Kymo Therapeutics through to clinical proof of concept. Newly-founded Kymo will use Medicxi’s money to further Metabrain Research’s work on inhibitors of kynurenine metabolism (KMO), a mechanism of action the partners think could address metabolic diseases including Type 2 diabetes. Thursday, October 6, 2016 As it looks to boost its presence in East Asia, and its R&D capacity, German Merck says it has launched an “M Lab Collaboration Center” in the Songdo district of Incheon, Korea--a burgeoning biotech hub in Asia. Thursday, October 6, 2016 When Theranos CEO Elizabeth Holmes presented a new device at a conference this summer, it seemed to be a bid to distract from the company’s much-criticized blood testing tech. Now, Theranos is abandoning its fingerprick blood tests entirely so it can focus on its new tabletop blood-testing system. | This week's sponsor is FierceBiotech. | | | FierceBiotech Presents:
A Half Day Executive Summit
Hosted at the Royal Society of Medicine, London
R&D Challenges: A UK Perspective
Cocktail Reception to follow
27 October, 2016
Register Now! |
| | | IPO-seeking AzurRX Biopharma has once again lowered its planned deal size as it battles headwinds in the market. Story The Michael J. Fox Foundation has given out a research grant to Asceneuron for its Parkinson’s R&D work. Release Fierce 15 winner Orchard Therapeutics has opened its doors to a new site in Foster City, CA. Statement Catabasis Pharmaceuticals says a part of its DMD trial has shown positive results. Release CAR-T player Kite has enrolled the first patient in its early-stage study combining Roche’s recently approved PD-L1 atezolizumab with its KTE-C19. Statement | |
|
Resources Presented by: Covance The role of health economic data has never been more important. Presented by: Covance Leading manufacturers increasingly employ stakeholder research early in development to better identify the needs of patients and providers. Presented By: ISR Reports ISR’s Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021 report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what the marketplace will look like in five years. Presented By: ISR Reports ISR’s CRO Quality Benchmarking – Phase II/III Service Providers (8th Edition) report provides a Consumer Reports-style analysis of Phase II/III CRO service quality from hundreds of users who rated 44 Phase II/III CROs across 26 critical dimensions of quality. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! Presented by: Biotech Primer This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance. Master of Science in Bioinformatics at Northeastern University Fall 2016, Spring 2017 Courses AdvaMed 2016: The MedTech Conference in Minneapolis October 17-19, 2016 | Minneapolis, MN Cannabis-Based Therapies November 30–December 1, 2016 | San Francisco, CA Drug Development Boot CampTM 2016 November 16-17, 2016 | Boston, MA Clinical Diagnostics & Research November 2-3, 2016 BioImmersion: In Depth Biotech for the Non-Scientist October 5-7, 2016 | Chicago, IL FierceBiotech Executive Summit October 27, 2016 | London CBI’s 7th West Coast Compliance Congress November 9-10, 2016 | San Francisco, CA | 